ABSTRACT
Thyroid storm is a rare clinical condition, and failure in management can lead to multiorgan failure and carries a high mortality. The comprehensive treatment approach is the administration of antithyroid drugs and radioactive iodine and thyroidectomy. The treatment option of therapeutic plasmapheresis (TP) should be considered as a stabilizing measure, especially when patients have failed or can not tolerate conventional treatment. This case report aimed to share that TP might be an alternative approach to be added to standard treatment methods in life-threatening conditions.
Keywords: Thyroid storm, therapeutic plasmapheresis, case report
References
1
Burch HB, Wartofsky L. Life threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am 1993,22:263-77.
2
Akamizu T, Satoh T, Isozaki O, Suzuki A, Wakino S, Iburi T, et al. Diagnostic criteria, clinical features, and incidence of thyroid storm based on nationwide surveys. Japan Thyroid 2012;22:661-79.
3
Galindo RJ, Hurtado CR, Pasquel FJ, Tome RG, Peng L, Umpierrez GE. National trends in incidence, mortality, and clinical outcomes of patients hospitalized for thyrotoxicosis with and without thyroid storm in the United States, 2004-2013. Thyroid 2019;29:36-43.
4
Ashkar FS, Katims RB, Smoak WM, Gilson AJ.Thyroid Storm Treatment with Blood Exchange and Plasmapheresis. JAMA 1970 Nov 16;214:1275-9
5
Tirotoksikoz ve Hipertiroidi. Tiroid Hastalıkları Tanı ve Tedavi Kılavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği (ISBN: 978-605-4011-15-5) 2015, Bölüm 8, s54-67.
6
Min SH, Phung A, Oh TJ, Han KS, Kim MJ,3 Kim JM , et al.Therapeutic plasmapheresis enabling radioactiveiodine treatment in a patient with thyrotoxicosis. J Korean Med Sci 2015;30:1531-4.
7
Muller C, Perrin P, Faller B, Richter S, Chantrel F. Role of plasma exchange in the thyroid storm. Ther Apher Dial 2011;15:522-31.
8
Szczepiorkowski ZM, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, et al. Guidelines on theuse of therapeutic apheresis in clinical practice: evidence based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010;25:83-177.
9
McLeod BC, Sniecinski I, Ciavarella D, Price TH, Randels MJ, Smith JW. Frequency of immediate adverse effects associated with therapeutic apheresis.Transfusion 1999;39:282-8.
10
Herrmann J, Hilger P, Kruskemper HL. Plasmapheresis in thetreatment of thyrotoxic crisis (measurement of half-concentration times for free and total T3 and T4). Acta Endocrinol Suppl (Copenh) 1973;173:22.
11
Petry J, Van Schil PE, Abrams P, PG Jorens. Plasmapheresis as effective treatment for thyrotoxic storm after sleeve pneumonectomy. Ann Thorac Surg 2004;77:1839-41.
12
Koball S, Hickstein H, Gloger M, Hinz M, Henschel J, Stange J, et al.Treatment of thyrotoxic crisis with plasmapheresis and single-pass albumin dialysis: a case report. Artif Organs 2010;34:E55-8.
